University of Iowa Carver College of Medicine, Iowa City, IA, USA.
BMJ. 2013 Jun 13;346:f2743. doi: 10.1136/bmj.f2743.
To evaluate studies assessing the effectiveness of a bundle of nasal decolonization and glycopeptide prophylaxis for preventing surgical site infections caused by Gram positive bacteria among patients undergoing cardiac operations or total joint replacement procedures.
Systematic review and meta-analysis.
PubMed (1995 to 2011), the Cochrane database of systematic reviews, CINAHL, Embase, and clinicaltrials.gov were searched to identify relevant studies. Pertinent journals and conference abstracts were hand searched. Study authors were contacted if more data were needed.
Randomized controlled trials, quasi-experimental studies, and cohort studies that assessed nasal decolonization or glycopeptide prophylaxis, or both, for preventing Gram positive surgical site infections compared with standard care.
Patients undergoing cardiac operations or total joint replacement procedures. DATA EXTRACTION AND STUDY APPRAISAL: Two authors independently extracted data from each paper and a random effects model was used to obtain summary estimates. Risk of bias was assessed using the Downs and Black or the Cochrane scales. Heterogeneity was assessed using the Cochran Q and I(2) statistics.
39 studies were included. Pooled effects of 17 studies showed that nasal decolonization had a significantly protective effect against surgical site infections associated with Staphylococcus aureus (pooled relative risk 0.39, 95% confidence interval 0.31 to 0.50) when all patients underwent decolonization (0.40, 0.29 to 0.55) and when only S aureus carriers underwent decolonization (0.36, 0.22 to 0.57). Pooled effects of 15 prophylaxis studies showed that glycopeptide prophylaxis was significantly protective against surgical site infections related to methicillin (meticillin) resistant S aureus (MRSA) compared with prophylaxis using β lactam antibiotics (0.40, 0.20 to 0.80), and a non-significant risk factor for methicillin susceptible S aureus infections (1.47, 0.91 to 2.38). Seven studies assessed a bundle including decolonization and glycopeptide prophylaxis for only patients colonized with MRSA and found a significantly protective effect against surgical site infections with Gram positive bacteria (0.41, 0.30 to 0.56).
Surgical programs that implement a bundled intervention including both nasal decolonization and glycopeptide prophylaxis for MRSA carriers may decrease rates of surgical site infections caused by S aureus or other Gram positive bacteria.
评估针对心脏手术或全关节置换术患者的鼻腔去定植和糖肽预防措施的组合,以预防革兰阳性菌引起的手术部位感染的研究。
系统评价和荟萃分析。
PubMed(1995 年至 2011 年)、Cochrane 系统评价数据库、CINAHL、Embase 和 clinicaltrials.gov 被用于确定相关研究。手检相关期刊和会议摘要。如果需要更多数据,会联系研究作者。
随机对照试验、准实验研究和队列研究,评估鼻腔去定植或糖肽预防措施,或两者结合,以预防革兰阳性手术部位感染与标准护理相比。
接受心脏手术或全关节置换术的患者。
两名作者独立从每篇论文中提取数据,并使用随机效应模型获得汇总估计值。使用 Downs 和 Black 或 Cochrane 量表评估偏倚风险。使用 Cochran Q 和 I(2)统计量评估异质性。
共纳入 39 项研究。17 项研究的汇总结果表明,当所有患者接受去定植时(汇总相对风险 0.39,95%置信区间 0.31 至 0.50),鼻腔去定植对金黄色葡萄球菌(Staphylococcus aureus)相关手术部位感染具有显著的保护作用(0.40,0.29 至 0.55)和当仅定植金黄色葡萄球菌携带者时(0.36,0.22 至 0.57)。15 项预防研究的汇总结果表明,与使用β内酰胺类抗生素(0.40,0.20 至 0.80)相比,糖肽预防对耐甲氧西林金黄色葡萄球菌(methicillin resistant S aureus,MRSA)相关手术部位感染具有显著的保护作用,而对甲氧西林敏感金黄色葡萄球菌(methicillin susceptible S aureus,MSSA)感染的风险因素无显著影响(1.47,0.91 至 2.38)。7 项研究评估了仅针对 MRSA 定植患者的去定植和糖肽预防措施的组合,发现针对革兰阳性菌的手术部位感染具有显著的保护作用(0.41,0.30 至 0.56)。
实施包括鼻腔去定植和 MRSA 携带者糖肽预防措施的捆绑干预措施的手术项目,可能会降低由金黄色葡萄球菌或其他革兰阳性菌引起的手术部位感染的发生率。